Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy

Author(s):: Dirven, L.; Klarenbeek, N.B.; Broek, M. van den; Groenendael, J.H.L.M. van; Sonnaville, P.B.J. de; Kerstens, P.J.S.M.; Huizinga, T.W.J. (0000-0001-7033-7520); Dijkmans, B.A.C.; Lems, W.F.; Allaart, C.F.

Published: 2013
Publication type: Article / Letter to editor

Alanine transferase (ALT)MethotrexateRheumatoid arthritis

Date issued: 2013-05-31
Language: English
Is part of: Clinical Rheumatology (2013), Vol. 32, no. 5, p. 585-590
hdl: 1887/98405
doi: 10.1007/s10067-012-2136-8